| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850396 | American Journal of Kidney Diseases | 2006 | 7 Pages |
Abstract
Conclusion: A 12-month treatment with ramipril did not cause significant regression of left ventricular hypertrophy in normotensive hemodialysis patients. Results may suggest that the renin-angiotensin system has little role in the pathogenesis of mild left ventricular hypertrophy in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Wen-Chung MD, Yao-Ping MD, I.-Feng DrPH, Shao-Yuan MS, Chen-Huan MD,